Mechanism of Action of Nonsteroidal Anti-inflammatory Drugs

1998/03/01 by John R. Vane, John R Vane, Regina M Botting · 27 citations
Medicine · Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics · #Inflammatory mediators and NSAID effects #Eicosanoids and Hypertension Pharmacology #Pharmacogenetics and Drug Metabolism

paper · doi:10.1016/s0002-9343(97)00203-9

Cited by

• Cyclo‐oxygenase isoenzymes: physiological and pharmacological role
• Sulfone and sulfoxide-containing pharmaceuticals: targets, pharmacological properties and SAR studies
• Salicylate induces tinnitus through activation of cochlear NMDA receptors. [europepmc]
• Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study. [europepmc]
• Expression of COX-1 and COX-2 in a clinical model of acute inflammation. [europepmc]
• The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. [europepmc]
• Paradigm shift in the pharmacological management of periodontal diseases. [europepmc]
• Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia? [europepmc]
• Imperatorin possesses notable anti‑inflammatory activity in vitro and in vivo through inhibition of the NF‑κB pathway. [europepmc]
• Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies. [europepmc]
• Prevention and treatment of uncomplicated lower urinary tract infections in the era of increasing antimicrobial resistance-non-antibiotic approaches: a systemic review. [europepmc]
• Relationship of the Phytochemicals from Coffee and Cocoa By-Products with their Potential to Modulate Biomarkers of Metabolic Syndrome In Vitro. [europepmc]
• Considerations in selecting postoperative analgesia for pregnant sheep following fetal instrumentation surgery. [europepmc]
• Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia. [europepmc]
• Vaccines and Therapies in Development for SARS-CoV-2 Infections. [europepmc]
• Bioresponsive drug delivery systems for the treatment of inflammatory diseases. [europepmc]
• Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes. [europepmc]
• Anti-Inflammatory Action and Mechanisms of Resveratrol. [europepmc]
• Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications. [europepmc]
• Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System. [europepmc]
• Efficacy of Polyphenols in the Management of Dyslipidemia: A Focus on Clinical Studies. [europepmc]
• Chronic Diclofenac Exposure Increases Mitochondrial Oxidative Stress, Inflammatory Mediators, and Cardiac Dysfunction. [europepmc]
• From NSAIDs to Glucocorticoids and Beyond. [europepmc]
• Chronic Pain in the Elderly: Mechanisms and Perspectives. [europepmc]
• Recent advances in pain management based on nanoparticle technologies. [europepmc]
• The Role of Resveratrol in Eye Diseases-A Review of the Literature. [europepmc]
• Progress in regulating inflammatory biomaterials for intervertebral disc regeneration. [europepmc]